Targeting the HER family with Pan-HER effectively overcomes resistance to cetuximab
Iida, M., Bahrar, H., Brand, T. M., Pearson, H. E., Coan, J. P., Orbuch, R. A., Flanigan, B. G., Swick, A. D., Prabakaran, P., Lantto, J., Horak, I. D., Kragh, M., Salgia, R., Kimple, R. J., Wheeler,Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-16-0012
Date:
July, 2016
File:
PDF, 704 KB
2016